Swallowable sponge could replace endoscopy for esophagitis monitoring

NCT ID NCT06501274

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a capsule sponge device as a less invasive alternative to endoscopy for checking how well treatment is working in people with eosinophilic esophagitis (a chronic allergic condition of the esophagus). Participants swallow a capsule attached to a string, which expands into a sponge to collect cell samples. The trial will compare the sponge's results with symptom questionnaires and see if it changes treatment decisions. It also measures patient pain and preference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
capsule sponge
What this could lead to
If successful, this could offer a simpler, less invasive way to monitor treatment response in eosinophilic esophagitis, reducing the need for repeated endoscopies.
What could go wrong
This is a small, single-site study. The capsule sponge may not provide enough tissue for analysis, and some patients may not be able to swallow it. It is not a treatment, only a monitoring tool.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • East and North Herts NHS Trust

    Stevenage, Hertfordshire, SG1 4AB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.